ANDREA DAVIS: Open Payments
NPI 1487178992 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 24 payments from 12 companies in 2025. Trend: 2023 $1,067 · 2024 $335 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $136 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $37 |
| Lundbeck LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
Products named: REXULTI, QULIPTA, FANAPT, ZENPEP, Dexcom G6 Transmitter, ELIQUIS, LINZESS, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
